Hints and tips:
Related Special Reports
...London-based healthcare investor GHO Capital has this year hired advisers from JPMorgan to oversee a sales process for FairJourney Biologics, a contract research organisation that works on behalf of pharma...
...If the trials approved by the Medicines and Healthcare products Regulatory Agency are successful, the drug will be the first cancer therapy developed on the island of Ireland....
...Recent trial data showed that Wegovy cut the risk of serious cardiac events by about 20 per cent....
...Apian to build on a drone trial held earlier this year....
...“Our vision is that in 10 to 15 years time, genetic information will be ubiquitous in healthcare systems,” he said....
...We all maintain the notion that healthcare is intended to help and heal. But the truth is, there is a difference in how men and women are supported by healthcare systems and providers....
...This is the first time a former US president has stood trial on criminal charges and follows last week’s surprisingly swift appointment of a jury....
...The comments come as the UK regulator, the Medicines and Healthcare products Regulatory Agency, is assessing the first treatments to target a plaque that triggers Alzheimer’s, the biggest cause of dementia...
...However, modelling by healthcare data company Airfinity based on the trial data estimated that to prevent one heart attack, stroke or cardiovascular-related death, 67 people would need to take Wegovy for...
...The Medicines and Healthcare Products regulatory agency first authorised Mounjaro, also known as tirzepatide, in November but not enough of the regular format of the drug was available to supply the UK....
...Also, we go long healthcare, short Tesla, and short private clubs....
...The NHS has been prescribing puberty blockers since 2011, but in March it said they would be available to children in England only as part of clinical research trials....
...“The company’s main biological asset are NHPs used for pre-clinical trials....
...The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a group of blue-chip healthcare investors, according to three people familiar...
...Last month, 23andMe announced that the first participant had been dosed in a Phase 1 clinical trial for an antibody that counters advanced solid tumours....
...The clinical trial was one of the first big decisions Jørgensen made after taking over as CEO in 2017....
...US start-up Intellia Therapeutics has launched the first late-stage trial for an in-vivo Crispr treatment for a rare heart condition. The costs are also a strain for higher-income countries....
...Lange said the trial also showed the drug had an impact on other conditions such as kidney disease....
...Our findings underscore the potential impact of cash on public health and on healthcare infrastructure in many countries, including those in Africa, already overburdened before a crisis hits....
...Macron has backed Dussopt to remain in his post during the four-day trial, which began on Monday....
...“The biological mechanisms underlying these findings are likely multiple, remain unclear and deserve detailed longitudinal study and therapeutic trials,” Zandi said....
...(The Verge) — The computing pioneer helping AI see (Quanta) — Inside the jeering wildness of the SBF trial overflow rooms (NY Mag) — Dollarising Argentina (Phenomenal World) — The murky math of the New...
...Audax went as far as to describe a HIG-led inquiry into Mobileum’s accounting practices as a “Stalinist show trial”....
...The abandoned asundexian trial “is a major setback for Bayer”, said Markus Manns, a portfolio manager and healthcare expert at Union Investment, Germany’s third-largest asset manager....
...The problem is that too many drug trials have failed. Merck knows how that feels. Its shares slumped 12 per cent on Wednesday after a multiple sclerosis medicine flopped in late-stage trials....
International Edition